Approval granted for patients with generalized myasthenia gravis or chronic inflammatory demyelinating polyneuropathy read on >
FDA Approves Self-Injection of Vyvgart Hytrulo
A little about: Weekly Sauce
All Sauce from Weekly Sauce:
New Trial Will Test Gene-Edited Pig Liver for Sudden Liver Failure Patients
A new clinical trial will soon test if a pig liver can help people whose own livers have suddenly stopped working. The hope? That animal organs can temporarily filter a patient’s blood, giving their own liver time to rest and possibly recover. The U.S. Food and Drug Administration (FDA) has approved the first-of-its-kind study, according… read on > read on >
Autism Rates Rise Again, Now Affecting 1 in 31 U.S. Children
Autism diagnoses are on the rise again, with about 1 in 31 U.S. children affected, according to a new report from the U.S. Centers for Disease Control and Prevention (CDC). The latest data, from 2022, shows a jump from the 2020 estimate of 1 in 36. The report looked at health and school records for… read on > read on >
Brisk Walking Lowers Risk Of Heart Rhythm Disorders
Long brisk walks might lower a person’s risk for heart rhythm problems, a new study says. Folks who stride faster than 4 miles per hour have a 43% lower risk of developing an abnormal heart rhythm, compared with those who amble at a pace of less than 3 miles an hour, researchers reported April 15… read on > read on >
Timing Might Be Everything With Asthma Inhalers
Folks with asthma might better control their symptoms by precisely timing when they use their inhaler, a new study says. A single daily preventive dose of inhaled corticosteroid is best taken at mid-afternoon for effective asthma control, researchers reported April 15 in the journal Thorax. That timing will suppress the usual nighttime worsening of symptoms… read on > read on >
FDA Approves Combo of Opdivo Plus Yervoy for Advanced Liver Cancer
The CheckMate-9DW trial showed significant overall survival benefit versus lenvatinib or sorafenib read on >
Pfizer Ends Testing of Obesity Pill After Possible Liver Injury
Pfizer has stopped developing a once-daily pill to treat obesity after a person in a clinical trial showed signs of a possible liver injury. The company said the injury went away after the person stopped taking the drug, called danuglipron, The Associated Press reported. The pill was in early testing to help determine the best… read on > read on >
New Antibiotic May Be Effective in Treating Gonorrhea
A newly approved antibiotic to treat urinary tract infections may also help fight drug-resistant gonorrhea, a new study shows. The medication, called gepotidacin, could become the first new gonorrhea treatment since the 1990s. In an international study of more than 600 people, researchers found that it worked just as well as current standard treatments. “Gepotidacin… read on > read on >
Smart Shirt Might Predict Heart Problems
A “smart shirt” equipped with an electrocardiogram (ECG) can help identify folks who are at higher risk of heart disease, a new study says. The shirt monitors people’s heart rate recovery after exercise, tracking the time it takes for their heart to return to a normal rhythm. “The heart’s response to exercise provides us with… read on > read on >
Gun Violence Leads To Skipped Dental Visits, Lost Teeth
Gun violence is bad for dental health, a new study says. More specifically, people are less likely to go to the dentist in neighborhoods with higher levels of firearm violence, researchers report in the American Journal of Preventive Medicine. These neighborhoods subsequently experience higher rates of tooth loss. And these effects increase: For every additional… read on > read on >